Management of immune thrombocytopenia in adults: a population‐based analysis of the French hospital discharge database from 2009 to 2012

Summary The present study describes the current clinical practice and hospital management of adults with immune thrombocytopenia ( ITP ) between 2009 and 2012 in France, based on the national discharge hospital database. Adult ITP patients were managed almost exclusively in public hospitals. A relatively stable number of patients, around 3200 per year, were hospitalized for ITP annually over the 4‐year period, about two‐thirds of whom were newly‐diagnosed ITP . Re‐hospitalizations tended to decrease over the study period. Intravenous immunoglobulin administration, concerning half of ITP hospitalized patients, and rituximab administration were stable over time, whereas a slight decrease of splenectomies was observed.